Cooper Consumer Health (PRIVATE.COOPERCH)

Overall impact
C (43)

Commentary

Cooper Consumer Health is an average overall performer. With a 'C' rating of 42.9 for overall impact (30th percentile compared to all companies), Cooper Consumer Health ranks 249th out of 260 industry peers, behind Catalyst Pharmaceuticals, Agios Pharmaceuticals, Pharmaron Beijing H and 245 others, and ahead of Perrigo, FIS, Novacap and 8 others. On top material causes for Cooper Consumer Health's industry (Pharmaceuticals), Cooper Consumer Health performs well in Child and Maternal Health (95.1 score), Child and Maternal Health (95.1), Child and Maternal Health (95.1) and 15 other causes where it received an 'A' score and performs poorly in Sustainable Use of Natural Resources (26.5 score), Racial Justice and Civil Rights (0.0), Accountable Institutions (0.0) and 66 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.COOPERCH
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1961
Employees
161
Sector
Health Care
Industry
Pharmaceuticals
Sub-industry
Pharmaceuticals
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Netherlands
Share classes
PRIVATE.COOPERCH
Description
Manufacturer of consumer health products intended to serve Western European countries and Hong Kong. The company is engaged in developing, manufacturing, researching and selling pharmaceutical products including tablets, film-coated tablets and capsules in bottles or blister packs.
Material causes
Ethos considers the following causes material for Cooper Consumer Health, based on its industry sub-industry Pharmaceuticals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.